Tacrolimus — Class I drug recall D-1168-2022
Terminated recall by Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy, reported 2022-06-15, distributed in CA. Subpotent drug
| Recall number | D-1168-2022 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy, Berkeley, CA, United States |
| Recall initiated | 2022-04-15 |
| Classified | 2022-06-27 |
| Reported by FDA | 2022-06-15 |
| Terminated | 2022-11-07 |
| Distributed | CA |
| Quantity | 950 mls |
| Reason classes | potency |
| Expiration dates | 2022-07-07 |
Product
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704
Reason for recall
Subpotent drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1168-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.